CSC
AVNS

Caldwell Sutter Capital’s Avanos Medical AVNS Stock Holding History

Caldwell Sutter Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3
Closed -$37 – 870
2025
Q2 		$37 Hold
3
– – ﹤0.01% 840
2025
Q1 		$43 Hold
3
– – ﹤0.01% 875
2024
Q4 		$48 Hold
3
– – ﹤0.01% 882
2024
Q3 		$72 Hold
3
– – ﹤0.01% 887
2024
Q2 		$60 Hold
3
– – ﹤0.01% 902
2024
Q1 		$60 Hold
3
– – ﹤0.01% 900
2023
Q4 		$67 Hold
3
– – ﹤0.01% 934
2023
Q3 		$61 Sell
3
-16
-84% -$363 ﹤0.01% 869
2023
Q2 		$486 Buy
+19
New +$500 ﹤0.01% 825

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Caldwell Sutter Capital's AVNS Position: Q3 2025 in Review

Caldwell Sutter Capital sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 3 shares — an estimated $37 sold.

Caldwell Sutter Capital first reported a position in AVNS in Q2 2023 and held it in 9 quarters. The position peaked at $486 in Q2 2023. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Caldwell Sutter Capital reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
  • Caldwell Sutter Capital sold 3 Avanos Medical shares in Q3 2025, an estimated $37.
  • Caldwell Sutter Capital first reported a position in Avanos Medical in Q2 2023 and held it in 9 quarters.
  • Caldwell Sutter Capital's Avanos Medical position peaked at $486 in Q2 2023.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Caldwell Sutter Capital's 13F filing for Q3 2025, filed 29 Oct 2025.